-
18769-5A cyclic thiopeptide antibiotic first isolated from S. bernensis inhibits protein biosynthesis in Gram positive bacteria through binding with ribosomal subunits induces the transcriptional activator TipA in Streptomyces.
-
B1668-100 mgBerteroin is a Erucin homolog that may exhibit antioxidative and anti-androgenic activities. Berteroin is an isothiocyanate (ITC) compound that decreases androgen receptor levels in prostate cancer cells.
-
B1668-25 mgBerteroin is a Erucin homolog that may exhibit antioxidative and anti-androgenic activities. Berteroin is an isothiocyanate (ITC) compound that decreases androgen receptor levels in prostate cancer cells.
-
B1668-500 mgBerteroin is a Erucin homolog that may exhibit antioxidative and anti-androgenic activities. Berteroin is an isothiocyanate (ITC) compound that decreases androgen receptor levels in prostate cancer cells.
-
B1668-50 mgBerteroin is a Erucin homolog that may exhibit antioxidative and anti-androgenic activities. Berteroin is an isothiocyanate (ITC) compound that decreases androgen receptor levels in prostate cancer cells.
-
17880-10A sulforaphane analog found in cruciferous vegetables that demonstrates potent anti-inflammatory effects doubles the phase II enzyme quinone reductase activity in mouse hepatoma cells at 1.7 µM inhibits degradation of I&kappaB&alpha,
-
17880-25A sulforaphane analog found in cruciferous vegetables that demonstrates potent anti-inflammatory effects doubles the phase II enzyme quinone reductase activity in mouse hepatoma cells at 1.7 µM inhibits degradation of I&kappaB&alpha,
-
17880-5A sulforaphane analog found in cruciferous vegetables that demonstrates potent anti-inflammatory effects doubles the phase II enzyme quinone reductase activity in mouse hepatoma cells at 1.7 µM inhibits degradation of I&kappaB&alpha,
-
17880-50A sulforaphane analog found in cruciferous vegetables that demonstrates potent anti-inflammatory effects doubles the phase II enzyme quinone reductase activity in mouse hepatoma cells at 1.7 µM inhibits degradation of I&kappaB&alpha,
-
B1973-100 mgBesifloxacin is a fourth generation fluoroquinolone antibiotic that displays broad-spectrum antibacterial activity against aerobic and anaerobic bacteria and is effective against a wide range of ocular pathogens that exhibit resistance to other
-
B1973-250 mgBesifloxacin is a fourth generation fluoroquinolone antibiotic that displays broad-spectrum antibacterial activity against aerobic and anaerobic bacteria and is effective against a wide range of ocular pathogens that exhibit resistance to other
-
B1973-25 mgBesifloxacin is a fourth generation fluoroquinolone antibiotic that displays broad-spectrum antibacterial activity against aerobic and anaerobic bacteria and is effective against a wide range of ocular pathogens that exhibit resistance to other